375 related articles for article (PubMed ID: 26389987)
1. Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
Wharton W; Goldstein FC; Zhao L; Steenland K; Levey AI; Hajjar I
J Am Geriatr Soc; 2015 Sep; 63(9):1749-56. PubMed ID: 26389987
[TBL] [Abstract][Full Text] [Related]
2. Neurofibrillary Tangles and Conversion to Mild Cognitive Impairment with Certain Antihypertensives.
Wharton W; Zhao L; Steenland K; Goldstein FC; Schneider JA; Barnes LL; Gearing M; Yasar S
J Alzheimers Dis; 2019; 70(1):153-161. PubMed ID: 31177216
[TBL] [Abstract][Full Text] [Related]
3. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
[TBL] [Abstract][Full Text] [Related]
4. Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer's disease: a meta-analysis.
Ye R; Hu Y; Yao A; Yang Y; Shi Y; Jiang Y; Zhang J
Int J Clin Pract; 2015 Jun; 69(6):674-81. PubMed ID: 25721930
[TBL] [Abstract][Full Text] [Related]
5. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
[TBL] [Abstract][Full Text] [Related]
6. Statins and cognitive decline in older adults with normal cognition or mild cognitive impairment.
Steenland K; Zhao L; Goldstein FC; Levey AI
J Am Geriatr Soc; 2013 Sep; 61(9):1449-55. PubMed ID: 24000778
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors and Alzheimer's disease progression in older adults: results from the Réseau sur la Maladie d'Alzheimer Français cohort.
Soto ME; van Kan GA; Nourhashemi F; Gillette-Guyonnet S; Cesari M; Cantet C; Rolland Y; Vellas B
J Am Geriatr Soc; 2013 Sep; 61(9):1482-8. PubMed ID: 24000874
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system blockers affect cognitive decline and serum adipocytokines in Alzheimer's disease.
Furiya Y; Ryo M; Kawahara M; Kiriyama T; Morikawa M; Ueno S
Alzheimers Dement; 2013 Sep; 9(5):512-8. PubMed ID: 23142434
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer's dementia.
Xiong LY; Ouk M; Wu CY; Rabin JS; Lanctôt KL; Herrmann N; Black SE; Edwards JD; Swardfager W
Alzheimers Res Ther; 2021 Sep; 13(1):147. PubMed ID: 34479635
[TBL] [Abstract][Full Text] [Related]
10. The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status.
Ouk M; Wu CY; Rabin JS; Jackson A; Edwards JD; Ramirez J; Masellis M; Swartz RH; Herrmann N; Lanctôt KL; Black SE; Swardfager W
Alzheimers Res Ther; 2021 Feb; 13(1):43. PubMed ID: 33573702
[TBL] [Abstract][Full Text] [Related]
11. [The effect of angiotensin receptor blockers in cerebrovascular disorders and dementia: bonus in addition to the antihypertensive effect].
Kovács T
Ideggyogy Sz; 2014 May; 67(5-6):149-68. PubMed ID: 25087375
[TBL] [Abstract][Full Text] [Related]
12. Is Mild Cognitive Impairment a Precursor of Alzheimer's Disease? Short Review.
Janoutová J; Šerý O; Hosák L; Janout V
Cent Eur J Public Health; 2015 Dec; 23(4):365-7. PubMed ID: 26841152
[TBL] [Abstract][Full Text] [Related]
13. Impact of coronary heart disease on cognitive decline in Alzheimer's disease: a prospective longitudinal cohort study in primary care.
Bleckwenn M; Kleineidam L; Wagner M; Jessen F; Weyerer S; Werle J; Wiese B; Lühmann D; Posselt T; König HH; Brettschneider C; Mösch E; Weeg D; Fuchs A; Pentzek M; Luck T; Riedel-Heller SG; Maier W; Scherer M
Br J Gen Pract; 2017 Feb; 67(655):e111-e117. PubMed ID: 27993897
[TBL] [Abstract][Full Text] [Related]
14. Natural progression model of cognition and physical functioning among people with mild cognitive impairment and alzheimer's disease.
Handels RL; Xu W; Rizzuto D; Caracciolo B; Wang R; Winblad B; Verhey FR; Severens JL; Fratiglioni L; Joore MA; Wimo A
J Alzheimers Dis; 2013; 37(2):357-65. PubMed ID: 23948894
[TBL] [Abstract][Full Text] [Related]
15. Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia.
Han JY; Besser LM; Xiong C; Kukull WA; Morris JC
Alzheimer Dis Assoc Disord; 2019; 33(2):87-94. PubMed ID: 30633043
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
17. Effects of education on the progression of early- versus late-stage mild cognitive impairment.
Ye BS; Seo SW; Cho H; Kim SY; Lee JS; Kim EJ; Lee Y; Back JH; Hong CH; Choi SH; Park KW; Ku BD; Moon SY; Kim S; Han SH; Lee JH; Cheong HK; Na DL
Int Psychogeriatr; 2013 Apr; 25(4):597-606. PubMed ID: 23207181
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer's disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairment.
Schneider P; Buerger K; Teipel S; Uspenskaya O; Hartmann O; Hansson O; Minthon L; Rujescu D; Moeller HJ; Zetterberg H; Blennow K; Ernst A; Bergmann A; Hampel H
Biol Psychiatry; 2011 Jul; 70(2):145-51. PubMed ID: 21457948
[TBL] [Abstract][Full Text] [Related]
19. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
[TBL] [Abstract][Full Text] [Related]
20. The correlation between cerebral arterial pulsatility and cognitive dysfunction in Alzheimer's disease patients.
Lim JS; Lee JY; Kwon HM; Lee YS
J Neurol Sci; 2017 Feb; 373():285-288. PubMed ID: 28131207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]